Carole S. Ben-Maimon
2021 - Zafgen
In 2021, Carole S. Ben-Maimon earned a total compensation of $2.2M as President and Chief Executive Officer at Zafgen, a 58% decrease compared to previous year.
Compensation breakdown
| Bonus | $140,250 |
|---|---|
| Option Awards | $1,570,389 |
| Salary | $510,000 |
| Other | $13,184 |
| Total | $2,233,823 |
Ben-Maimon received $1.6M in option awards, accounting for 70% of the total pay in 2021.
Ben-Maimon also received $140.3K in bonus, $510K in salary and $13.2K in other compensation.
Rankings
In 2021, Carole S. Ben-Maimon's compensation ranked 5,609th out of 12,415 executives tracked by ExecPay. In other words, Ben-Maimon earned more than 54.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,609 out of 12,415 | 55th |
Division Manufacturing | 2,375 out of 5,508 | 57th |
Major group Chemicals And Allied Products | 1,030 out of 2,378 | 57th |
Industry group Drugs | 919 out of 2,099 | 56th |
Industry Pharmaceutical Preparations | 663 out of 1,549 | 57th |
Source: SEC filing on April 12, 2022.
Ben-Maimon's colleagues
We found one more compensation record of an executive who worked with Carole S. Ben-Maimon at Zafgen in 2021.
2021
Michael Celano
Zafgen